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"Never doubt that a small 
group of thoughtful, 
committed individuals can change the world; indeed, it's the 
only thing that ever has." - Margaret Meade 
Only four or five hospital networks in Southeastern Pa. are 
expected to survive the economic challenges over the 
next few years, according to a report by Standard & 
Poor's. 
Because of financial problems fueled by labor shortages, rising 
drug prices, managed care pressures, Philadelphia's 
population decline, the lack of a public hospital to treat the 
uninsured, and the rising cost of malpractice, the report said, 
marginal and weak hospitals may fail, while hospital networks 
such as Jefferson Health System, University of Pennsylvania 
Health System, Temple University Health System and Tenet 
Healthcare Corp. are likely to emerge as the area's dominant 
health care systems, reported the Philadelphia Inquirer. 
Hospitals that remain independent are likely to face increasing 
financial pressure, except for those that provide specialized 
services, such as the Fox Chase Cancer Center, Wills Eye 
Hospital, and Children's Hospital of Philadelphia, the 
Philadelphia Inquirer noted. The study also found that 
consolidation into larger networks has improved hospitals' 
ability to negotiate better contracts with health insurers, drug 
companies and other suppliers, but that narrow margins for 
most hospitals will leave little money to invest in new medical 
technology or equipment for patient care, the Philadelphia 
Inquirer added. (Philadelphia Inquirer, May 2, 2001) 
http:l/inq.philly.com/content/inquirer/2001/05/02/business/HOS 
PS02.htm 
While we are aware of the difficult financial challenges facing 
hospitals in Pennsylvania, it is certainly sobering to read a 
prediction (from presumably reliable S&P) that only a handful 
of larger hospital systems in this region will be left standing 
after a few years. 
One of the continued sources of pressure is the Pennsylvania 
malpractice crisis: "In the past two years, the cost of 
mandated professional liability insurance for health care 
providers has increased more that 30%. Those increases 
coupled with rising premiums for primary liability coverage 
have driven Pennsylvania's medical professional liability costs 
40-70% higher than in surrounding states." (The Hospital and 
Healthsystem Association of Pennsylvania- April2001) 
(Continued on Page 2) 
J 
(Continued from Page 1) 
Market forces are at woi'k in our Commonwealth: 
};> Neurosurgeons - down 10% in each of the last two years 
);;> Ob-Gyns- down 6.4% since 1997 
- those delivering or assisting in delivering babies 
down 7.5% 
);;> Psychiatrists - down 11% 
);;> Five times the number of Pennsylvania physicians retired 
in 2000 as in 1999. 
Thus, the malpractice premium increase is costing hospitals 
and health systems, not just health care providers. All these 
funds are flowing out of health care into an antiquated state 
tort system that is begging for meaningful reform by our 
Pennsylvania legislature. I am convinced that this problem is 
now having a negative impact on our health care performance 
as a state - and Pennsylvania is one of the last holdouts in the 
nation against some type of tort reform. Our neighbors in New 
Jersey, Delaware and New York do not share this problem; 
this is only Pennsylvania. 
Life is the little shadow which runs across the grass and loses 
itself in the sunset. Crowfoot - Last words, 1890 
"I don1 get it- What's wrong with what we have now? 
(overheard in the LVH hallways) 
Ninety-five percent of physicians have witnessed a 
serious medical error, and 58 percent of health care 
providers say the health system is not very good. 
According to respondents of a Robert Wood Johnson 
Foundation survey of 600 physicians, 400 nurses and 200 
senior-level hospital executives conducted in March and April, 
61 percent of health care providers also said they accept 
common errors as routine practice, while 29 percent said they 
believe they can provide leadership to change the system, 
USA Today reported. The foundation said it will spend $20.9 
million over three years to fund Pursuing Perfection, an 
initiative involving projects by hospitals and physician groups 
to improve health care. ·The initiative has received more than 
220 applications, 12 of which will get money to develop 
business plans, and six will get up to $3.5 million to make 
changes throughout their systems, USA Today added. (USA 
Today, May 9, 2001) 
http://www.usatoday.com/usatonline/2001 0509/3301962s.htm 
Computer assisted physician order entry (CAPOE) is coming. 
California has legislated that all hospitals in that state will have 
a plan for CAPOE in place by 2002 and will implement that 
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plan by 2004. LVHHN is not as far ahead of the curve as we 
might think. Several regional hospitals have already been 
using some variation of the CAPOE theme. 
LVH·M 
The Electronic Medical Record Access and Chart Completion 
system (PIM 4.0) will be implemented on June 17, 2001. 
Important Dates to Remember 
June 4- old e-mail (7 year old green Screen) will no longer 
print. Everyone is encouraged to switch over to the upgraded 
Graphic user interface (GUI) e-mail. 
June 17- LVH-M lmnet PIM 4.0 
June 26 - TTU CAPOE 
Growing old is mandatory; growing up is optional. 
Physician Leadership 
At a time of ongoing change and instability in many areas of 
health care, it is perfectly natural to feel uneasy and even 
threatened. Everywhere we look, we can see change: drugs, 
surgical techniques, outcomes analysis, education methods, 
technology and now the OIM report suggesting that we change 
the ENTIRE SYSTEM of care. 
On the one hand, this is a time when the health care team 
looks to the physician as the natural team leader for stability, 
guidance and direction - and we can provide it because we 
never forget that the focus of all these advances is improved 
PATIENT care. The team looks to us for positive attitude and 
we set the tone -like it or not. 
On the other hand, physicians may be feeling queasy 
themselves about digesting all this change. Your medical staff 
leadership is very concerned about providing support 
mechanisms and safety nets (with each change) so that no 
one will be left behind - unless, of course, they choose that 
path. We will progress as a medical staff and an institution 
together. 
You have to dance like nobody's watching and love like it's 
never going to hurt. - Source unknown. 
(Continued on Page 3) 
(Continued from Page 2) 
Monitored Anesthesia Coverage (MAC) • Medicare Rule 
Changes 
Effective April 29, 2001, Medicare requires supporting 
documentation to justify MAC anesthesia for surgical or 
diagnostic procedures involving the entire integumentary 
system, including biopsies, excision of masses, colonoscopies 
and endoscopies. Medicare also requires supporting 
documentation for MAC anesthesia for MRI's. Medicare does 
not require justification when General anesthesia or Propofol 
infusions are used for these procedures. Basically, if the 
procedure is done with minimal or light sedation, Medicare is 
requiring that the attending surgeon (gastroenterologist, etc.) 
justify an additional payment for the anesthesia component. 
Some of the diagnoses that Medicare will accept as 








To obtain a copy ofthe MAC Medicare Policy, please contact 
Janet M. Seifert in Physician Relations at (610) 402-8590. 
Golfer: "I've played so poorly all day; I think I'm going to 
drown myself in that lake." 
Caddie: "I don't think you could keep your head down that 
long, Sir." 
Edward M. Mullin, Jr., MD 
Medical Staff President 
You are cordially invited to attend 
a VIP Reception at 
Lehigh Valley Hospital and Health Network's 
Newly Expanded Sleep Disorder Center 
on Wednesday, June 13, 2001 
3 to 7 p.m. 
1 T"" & Chew Streets 
Fourth Floor 
RSVP (610) 402-CARE by June 6 
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A meeting of the General Medical Staff will be held 
on Monday, June 11, beginning at 6 p.m. in the 
Auditorium of Lehigh Valley Hospital, Cedar Crest 
& I-78, and via videoconference in the First Floor 
Conference Room at LVH-Muhlenberg. All members 
of the Medical Staff are encouraged to attend. 
In conjunction with the General Medical Staff 
meeting, a Health Care Technology Fair will be held 
from 5:30 to 8 p.m., in the Anderson Wing Lobby at 
Cedar Crest & I-78. Displays and demonstrations 
will be available. Please plan to stop by for a few 
minutes before or after the meeting. Door prizes 
wi II be awarded. 
Physician Satisfaction by David M. caccese, MD 
As representatives of the Medical Staff, the members of Troika 
recently met with Nancy Stevens and Maryanne Falcone, 
Patient Representatives, and Jack Dunleavy from 
Organizational Development, to discuss the LVH Medical Staff 
physician satisfaction scores on the Press-Ganey surveys, 
which our hospitalized patients are asked to complete about 
two weeks after their discharge from the hospital. We learned 
a number of important things that I'll be sharing with you over 
the next few months. 
Most importantly, patients value the time we spend in their 
rooms at the bedside. This is "face-to-face" time. It gives the 
patient an opportunity to ask questions of their doctor, have 
those questions answered, and to have the plans for the 
remainder of the hospital stay addressed. Sitting in the room 
with the patient makes an even bigger difference in the 
patient's perception of the time and interest that the physician 
demonstrates for his/her problem. 
It's frightening to learn that many patients are unable to name 
their physicians. There are multiple reasons for this surprising 
fact. Patients are sometimes referred into the hospital by their 
personal physicians to be cared for by "specialists" who they 
may never have seen before. The specialists often work with 
multiple partners who may see the patient on different days 
during their hospital stay. Patients are frequenHy very ill and 
simply can't remember all of the physicians and staff who stop 
into their rooms. 
A simple solution to these problems is to be sure to introduce 
yourself to the patient when you come to the bedside. Tell 
them with whom you work. Tell them why you are there. Give 
them your professional card with your name and your group's 
name clearly indicated. By following these simple suggestions, 
our patients will be more likely to remember our names. 
Notes 
News from CAPOE Central 
We are getting close to the activation date for the LastWord 
upgrade on June 16, and the TTU will go live wit~ CAPOE by 
the end of the month. The Design Team had the1r last meeting 
on May 18, and is on a very well deserved hiatus until after go-
live. We will re-convene the Design Team to discuss the 
system after TTU gains some experience with CAPO E. 
Although full implementation of CAPOE throughout the 
hospitals will take some time, many of ~he physicians. and . 
providers will be affected when consulting on or working With 
CAPOE patients. The expectation is that physicians and 
providers will review orders and sign telephone orders fo.r 
CAPOE patients in the computer system. A benefit of th1s 
change is that physicians will be able to perform these 
functions from anywhere with LastWord access. 
Various modes of education and training will be provided for 
these improvements in the information systems. Of particular 
interest to physicians in the LastWord training will be the new 
Patient Lists, Medication Profile, Order Review, and the Viewer 
(to look up labs, etc.). For a list of training dates, please refer 
to the article on page 5. 
There will also be web-based training available for the 
LastWord upgrade. Users will be able to access this 
interactive training system at any time from any PC with a 
browser (in the hospital or at home). This will allow the users 
to receive training as it is needed, and refresh their education 
when necessary. 
CAPOE Training 
Training for CAPOE physicians and other providers will occur 
through several channels. The majority of the training will be 
one-on-one with users when their units in the hospital are 
ready to go-live with CAPOE. There are three excellent 
physician educators who will be available to meet with 
physicians at their convenience to provide training and ongoing 
support. There will be a very user-friendly reference guide that 
all CAPOE physicians will receive. It will walk the physician 
through the system and provide illustrations on how to use the 
system. A pocket guide will also be available that will illustrate 
the key points to Physician Order Entry. 
Live demonstrations, providing hands-on opportunities, will be 




7 a.m. to 5 p.m. Anderson Wing 
5:30 to 8 p.m. Anderson Wing 
7 a.m. to 5 p.m. Anderson Wing 
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1 urge all physicians to participate in the training. These new 
systems will improve patient care and ultimately make our lives 
easier. 
Please call me with any questions or if you would like a 
demonstration of CAPOE. 
Don Levick, MD, MBA 
(484) 884-4593 (office) 
(610) 402-5100 7481 (pager) 
Interested in Looking up Info on Your 
Patients from Anywhere??? 
If so, Channel Health provides a secured way to have access to 
IDX Lastword (Phamis) patient information in a read-only mode 
through the Internet. All you need is an Internet connectio~ 
and Internet Explorer 5.0. Also included in ChanneiHealth 1s 
Physician Homebase. This provides you with predefined (and 
easily customizable) links to medical journals, medical 
specialties, medical associations, government health sites, 
MDConsult, Continuing Medical Education (CME) credits, and 
MORE. 
For more information, please stop by the display after the 
General Medical Staff meeting on June 11, at Cedar Crest & 
1-78, or in the First Floor Conference Room at Lehigh Valley 
Hospital-Muhlenberg on June 28 from 7 a.m. to 5 p.m. If you 
cannot attend either of these showings, please contact the 1/S 
Helpdesk at (610) 402-8303 and ask for the Physteam. The 
Physteam can schedule an appointment to demonstrate this 
for you at a more convenient time. 
The next Greater Lehigh Valley Independent 
Practice Association Quarterly General 
Membership Meeting will be held on Monday, June 
25, at 6 p.m., in the hospital's Auditorium at Cedar 
Crest & I-78. 
This meeting will include information regarding the 
expanded vendor program. The LVPHO Preferred 
Vendor Program is entering into a partnership with 
the alternative care division of VHA, known as 
LaurusHealth Professional, a national purchasing 
organization. Your office manager is also invited to 
attend this portion of the meeting, from 6 to 6:30 
p.m., to learn how the program works. 
Reminder: To receive credit for your attendance, 
please remember to sign in. 
IDX LastWord Physician Training 
Education and training for improvements to the lOX LastWord 
information system, including use of the new Patient Lists, 
Micro Command, Medication Profile, Order Review, and the 
Viewer (to look up labs, etc.), will be provided as noted below. 
Attendance at any of the following sessions will cover what will 
be needed for physicians to use the new features of lOX 
LastWord, which will be implemented on June 16, 2001. In 
addition, members of the Information Services staff will be 
available, around the clock, in the Medical Staff Lounge at 
Cedar Crest & 1-78 and LVH-Muhlenberg from "go-live" on 
June 16 through June 18 to assist physicians and to answer 
questions. 
Classroom type training for the LastWord upgrade will occur at 
the following times and locations: 
Cedar Crest & 1-78 
JuneS 
7 to 8 a.m. 
noon to 1 p.m. 
6 to 7 p.m. 
June7 
?to 8 a.m. 
noon to 1 p.m. 
6 to 7 p.m. 
June 11 
?to 8 a.m. 
noon to 1 p.m. 
6 to 7 p.m. 
June 13 
Learning Resource Center - CC Library 
Learning Resource Center- CC Library 
Learning Resource Center- CC Library 
Learning Resource Center- CC Library 
Learning Resource Center- CC Library 
Learning Resource Center - CC Library 
Learning Resource Center- CC Library 
Learning Resource Center- CC Library 
Learning Resource Center- CC Library 
7 to 8 a.m. Learning Resource Center- CC Library 
noon to 1 p.m. Learning Resource Center - CC Library 
4:30 to 5:30 p.m. JDMCC 4th Floor 1/S Training Room 
6 to 7 p.m. Learning Resource Center- CC Library 
June 14 
noon to 1 p.m. JDMCC 4th Floor 1/S Training Room 
June 15 
7 to 8 a.m. JDMCC 4th Floor 1/S Training Room 
noon to 1 p.m. JDMCC 4th Floor 1/S Training Room 
June 18 
noon to 1 p.m. Learning Resource Center- CC Library 
June 19 
noon to 1 p.m. Learning Resource Center- CC Library 
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Lehigh Valley Hospital-Muhlenberg 
June7 
7 to 8 a.m. 
noon to 1 p.m. 
6 to 7 p.m. 
June 13 
Information Services Training Room- LVH-M 
Information Services Training Room- LVH-M 
Information Services Training Room - LVH-M 
noon to 1 p.m. Information Services Training Room- LVH-M 
June 14 
4:30 to 5:30p.m. Information Services Training Room- LVH-M 
17"' & Chew 
JuneS 
7 to 8 a.m. 
noon to 1 p.m. 
6to 7 p.m. 
June 12 
?to 8 a.m. 
noon to 1 p.m. 
6to 7 p.m. 
6th Floor CEDS Conference Room - 17 
6th Floor CEDS Conference Room - 17 
6th Floor CEDS Conference Room - 17 
6th Floor CEDS Conference Room - 17 
6th Floor CEDS Conference Room -17 
6th Floor CEDS Conference Room - 17 
Live demonstrations - providing hands-on opportunities will 
be available during the following times: 
June 5 - 7 a.m. to 5 p.m. - Anderson Wing, Cedar Crest & 1-78 
June 11 - 5:30 to 8 p.m. - Anderson Wing, Cedar Crest & 1-78 
(in conjunction with the General Medical Staff meeting) 
June 13- 7 a.m. to 5 p.m. -Anderson Wing, Cedar Crest & 1-78 
There will also be web-based training available for the 
LastWord upgrade. Users will be able to access this 
interactive training system at any time from any PC with a 
browser {in the hospital or at home). This will allow the users 
to receive training as it is needed, and refresh their education 
when necessary. 
Please email or call Craig Koller in the Center for Education at 
(61 0) 402-2413 with any scheduling questions. 
If you missed the Advanced Directives Fair and 
would like a packet of information geared to the 
needs of physicians, please contact Nancy Stevens, 
Patient Representative, at (610) 402-8222 or via 
e-mail. Included in the packet are sample 
directives and articles about talking with patients 
regarding their medical treatment wishes. 
June,2001 
Setting Up Your Default Patient List 
The first time you access Lastword 4.1. 7, you will note an 
asterisk (*) next to the Hotlist name in the Patient List Directory 
window (see Figure 1). This indicates Hotlist Is assigned as 
your default patient list. Hotlist is a user defined list that may 
be used for tracking purposes (e.g., you can include all 
Note asterisk 
next to Hotlist 
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diabetic patients in your Hotlist). Since patients are added to 
the Hotlist, upon initial entry no patients appear in the list. 
For practical purposes, it is best to change the default patient 
list to MyCensus. MyCensus is a system defined list of 
patients by physician group (i.e., all patients followed by your 
physician group are included in this list). 
Make Default 
button 
Figure 1 • The Physician Base Screen appearance when logging on the first time 
To change your default patient list from Hotlistto 
MyCensus: 
1. Click on MyCensus list name in the Patient List 
Directory window. The MyCensus list name 
highlights. 
2. Click on the Make Default button located beneath the 
Patient List Directory window. Note the asterisk that 
appeared adjacent to Hotlist is now next to 
MyCensus. 
Your default patient list is now MyCensus. Note in Figure 2 on 
Page 7 the Current Patient List window now contains the 
patients belonging to MyCensus. Also note the MyCensus list 
name located above the Current Patient List window. 
t".....:>l.oiUAJ..c. MICHAEL 
5C038 PASQUALE. MICHAEL 
7A048 LEVICK. DONALD L 
7C 01 LEVICK. DONALD L 
TT 02 LEVICK. DONALD L 
TT 03 LEVICK. DONALD L 
TT 04 LEVICK. DONALD L 
Note asterisk next 
to MyCensus 
Volume 1 Number 6 7 
Figure 2 • Physician Base Screen appearance after changing default patient list to MyCensus 
The Children's Hospital of Philadelphia 
Specialty Care .Center of the Lehigh 
Valley 
The new Children's Hospital of Philadelphia Specialty Care 
Center of the Lehigh Valley, a joint effort between CHOP and 
LVHHN, opened its doors to children in the community on 
February 12. Located on the campus of Lehigh Valley 
Hospital-Muhlenberg, the Specialty Care Center provides area 
families access to many pediatric specialty services, including 
oncology, endocrinology, pulmonary, cardiology and 
orthopedics, allowing children to stay closer to home for 
specialty outpatient care. 
The new, two-story facility includes a new ambulatory surgical 
suite at ground level and the Specialty Care Center on the 
upper floor. The child-friendly specialty care facility is 
equipped with 17 exam rooms, two procedure rooms, a 
therapy gym, and a pulmonary function lab. Adjacent to the 
main waiting room is a Family Resource Center-- a 
comfortable and inviting place where patients, parents and 
siblings can obtain more information about health topics of 
interest. The Family Resource Center is equipped with the 
latest pediatric healthcare publications and education 
information, plus a video library and viewing area, and several 
computers with relevant pediatric healthcare Web sites 
convenienHy bookmarked. 
Hours of operation for the Specialty Care Center are Monday 
through Friday, 8 a.m. to 5 p.m. For more information or to 
schedule appointments, please call (484) 884-CHOP. 
A special Family Fun Day to introduce the Specialty 
Care Center and its services to the community will take 
place on Saturday, June 2, from 11 a.m. to 3 p.m., at 
the new facility. Activities for children, entertainment and 
food, as well as tours of the new facility will be included in 
the day's events. 
Radiology News 
PET Update 
Early last month, the Section of Nuclear Medicine began to 
provide PET scan serviCes at Lehigh Valley Hospital, Cedar 
Crest & 1-78. The first patient had a 1.2 em. solitary pulmonary 
nodule which was benign by PET criteria. This saved the 
patient unnecessary biopsy, and the patient will be followed by 
serial CAT scans. The second patient had an indeterminate 
lesion in the perirectal area on serial MRI scans. The PET 
scan showed this to be consistent with recurrent tumor in this 
region, and the patient will receive aggressive therapy. The 
next three patients all had solitary pulmonary nodules, all of 
which were positive by PET criteria, and biopsies will be 
performed on these patients for histologic diagnosis. 
PET scans will replace Neotect scans for the workup of solitary 
pulmonary nodules and will replace CEA scans for the workup 
of recurrent colorectal carcinoma since PET has been shown 
to be more sensitive in these cases. In addition, PET scans 
are more sensitive than gallium scans for staging Hodgkins 
and Non-Hodgkins lymphoma and are recommended for this 
purpose. On the other hand, Prostascint scans are still 
recommended for staging of recurrent prostate cancer since 
PET has not been shown to be as effective in the evaluation of 
these patients. 
Currently, the state-of-the-art mobile PET scanner is available 
at LVH once a week. Patients can be scheduled by calling 
(610) 402-TEST and by following the prompts. PET scans are 
performed on an outpatient basis for the following criteria: 
solitary pulmonary nodules, staging of non small cell lung 
cancer, staging and work-up of lymphoma, recurrent colorectal 
cancer, and melanoma. 
If you have any questions regarding PET scans, please 
contact either Kathleen L. McDonald, MD, or Robert J. Rienzo, 
MD, in Nuclear Medicine at (610) 402-8373. 
Magnetic Resonance Spectroscopy 
Magnetic resonance spectroscopy (MRS) is a non-invasive 
means of measuring metabolites within tissue. Currently, its 
main applications have been in studies of the brain. Rather 
than generating an image, MR spectroscopy produces a graph 
that measures the presence of specific metabolites. 
Comparisons of the concentration of different metabolites in 
the abnormal brain can help differentiate disease processes 
that may have a similar appearance with conventional MRI 
imaging. 
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One use is differentiating neoplasm from a non-neoplastic 
process such a demyelinating disease, infarction, infection, or 
radiation necrosis. While any of these may produce a mass-
like appearance with conventional imaging, their spectra can 
be markedly different. MR spectroscopy is also useful in the 
diagnosis and management of certain metabolic diseases. 
At Lehigh Magnetic Imaging Center, three of the high field 1.5 
Tesla magnets are specially equipped to perform 
spectroscopy. MRS can be performed as an adjunct to 
conventional MR imaging. 
If you have any questions regarding MR spectroscopy or its 
potential use for any of your patients, please contact Elliot I. 
Shoemaker, MD, Vice Chairperson, Department of Radiology-
Diagnostic Medical Imaging, at (610) 402-8088. 
Coding Tip of the Month 
To code wound repairs more accurately, 
the following should be documented in the 
medical record: 
)o> Number of wounds repaired. 
)o> Anatomical sites of the wounds. 
)o> Length of wounds (in centimeters). 
)o> What type of repairs were performed: 
Simple, Intermediate, Complex, etc? 
)o> Was tendon, nerve, or blood vessel 
repair involved? 
On May 23, the Special Care Unit at Cedar 
Crest & I-78 relocated from the sixth 
floor to the second floor of the main 
hospital, adjacent to the Emergency 
Department. The telephone number has 
remained the same -- (610) 402-8730. 
'7he Difference" 
by George A. Arangio, MD 
It has been a busy 25 years at Lehigh Valley Hospital. It was a 
time of change for all of us. However, some things do not 
change. Our patients are dependent on our care and on our 
caring. It is a stressful commitment, and the responsibility is 
great. We divert ourselves from the unavoidable demands of 
our profession with our hobbies and our toys, some of us more 
successfully than others. The pressures are ever present. 
It was time for an examination and renewal. I needed to 
assess where and what I wished to be. As I rested from my 
successes and searched, I found the significance in what we 
do; the effort was therapeutic. 
It is seven o'clock in the morning of July 10, 2000 at the Union 
Memorial Hospital. I am a visiting foot and ankle clinician. Ten 
hours later, my colleagues and I have seen 70 patients. I am 
relaxed, smiling and satisfied. I am a physician observer "with 
no patient responsibility." Forced detachment is the difference; 
however, some things do not change. My host and his staff 
are completing their work: diagnosing and treating, casts off 
and casts on, record keeping, scheduling, billing, insurance 
forms, messages and questions. 
"Mrs. Jones, if you are going to speak to me in that tone, I will 
have to hang up the phone!" says one secretary. 
!~e care and the caring are accomplished. It is important, and 
1t 1s stressful. It goes on for four weeks, and I love each day. 
Being on sabbatical is different! 
I ~alk to work on a sunny, cool, August morning in Rochester, 
Minnesota. My colleagues receive me warmly, and I am 
assimilated among 12 research scientists and the Mayo 
Orthopedic staff. There is pressure in this easygoing mid-
western medical community. Their mission is to care for 
patients, teach, complete research and publish. The libraries 
are jammed until late evening, and the computers "hum• 
endlessly. I wrestle with my assigned keyboard, day and night, 
Saturdays and Sundays, but it is a leisure endeavor. There 
are. no pressing deadlines, no grant applications, and no 
pat~~nt care respons!bilities. I am working, reflecting and 
sm1hng. I am tranquil while being productive. I will try to 
convey the experience to whoever will listen. It is different. 
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In Bella Bologna the "ricercare, • the sabbatical, the search 
c?n~inues. 1. am a continent away, but the scene is eerily 
s1m1lar. Am1dst the beauty, elegance and antiquity, the 
surgical work is completed with excellence. At the lstituto 
Ortopedico Rizzoli, the workdays are long, and the pace is 
surprisingly American; however there are notable distinctions. 
The paperwork is pertinent and, therefore, less. Medical 
insurance is one-tenth of the cost compared to costs in 
America. There is a rigid medical hierarchy and the financial 
rewards are usually smaller. But, some things do not change. 
The stresses to deliver good care and to advance 
professionally and financially are obvious. The introspective 
Italians share their hearts with whoever will listen. 
• And how is it in America?" they ask. 
"About the same,• I respond. 
It was a wonderful experience to assist my Italian colleagues in 
their work and share their friendship. 
The last quarter of my sabbatical was spent at the Carolina's 
Medical Center in Charlotte, North Carolina. The Southern 
born and bred were friendly companions. Good manners and 
a smile are prerequisites in the South. Nowhere was there 
more pressure to get the medical work completed than in 
pleasant Charlotte. The physicians and staff worked long 
hours, solved difficult problems, and were driven caregivers. 
Some were transplanted from the North. You could tell who 
was ~rom where! For m~, i~ was another six weeks of learning, 
meeting people, and enJOYing the difference. 
~am home once. ~ore practicing orthopedic surgery. It is 
Intellectually, sp1ntually, and physically demanding. I have 
confirmed that our greatest assets are the people with whom 
we work. I have learned that some of our stresses are self-
inflicted. I shall periodically step away to stop to look and 
listen: ~t is.refreshing, relaxing and therapeutic. I appreciate 
the d1st1nction between success and significance. 
My "Modest Proposal" is that all physicians must take six 
months sabbatical every seven years. 
Ju 
Good Shepherd Specialty Hospital-
Allentown 
Following is an overview of the Good Shepherd Specialty 
Hospital-Allentown for the time period of July 1, 2000 through 
March 31,2001. 
~ Occupancy - 43.9% 
Admissions to Programs 
~ Pulmonary/ventilator- 38 
~ Complex medical- ·1 04 
~ Transitional rehabilitation - 22 
~ Average length of stay- 25.31 days 
Discharge Destinations 
~ Home-48 
~ Rehab- 22 
~ Subacute 3 
~ Skilled- 29 
~ Assisted Living - 3 
~ Planned readmissions - 8 
~ Acute unplanned - 19 
~ Inpatient Hospice- 1 
~ Expired- 19 
Total Discharges - 152 
Highlights 
~ New cardiac program underway 
~ All beds have telemetry capability 
~ Nurses attend LVH cardiac training classes 
);> 231 Physicians on staff 
FYI 
Medical Records - See charge nurse for after-hour requests 
Key Contacts 
Don Yoder- Administrator/CEO- (610) 402-8559 
Beverly Snyder- Director of Nursing/Assistant Administrator-
(610) 402-8564 
Tammy Winterhalt- Medical Staff Coordinator- (610) 402-
8564 
Angela Ritter- Director HIM/Outcomes- (610) 402-7674 




Karen A. Bretz, MD, Vice Chairperson for Quality Assurance, 
Department of Anesthesiology, was recently informed that she 
was selected to attend the professional development program 
-- "Mid Career Women Physicians" -- which will be held July 
21-23 in Washington, DC. Jointly sponsored by the 
Association of American Medical Colleges and Harvard 
Medical School, the program has a competitive application 
process with admission limited to one or two individuals per 
organization. 
Papers, Publications and Presentations 
Kelly M. Freed, MD, Division of Diagnostic Radiology, co-
authored two articles which were published in the April, 2001 
issue of the American Journal of Roentgenology. The first 
article, "The Spectrum of Abdominal Venous CT Findings in 
Blunt Trauma," reviews common venous injuries such as 
mesenteric hematomas, portal and hepatic vein injuries, as 
well as uncommon ones such as contained rupture of the IVC 
and traumatic fat herniation into the IVC. The other article is 
titled "The Anterior Iliac Separation: Alternative Index for 
Pelvic Morphometry in Fetuses with Down Syndrome." A 
widened iliac angle has been proposed as a marker for Down 
Syndrome on prenatal sonography by several investigators. 
This is the first article to investigate the linear measurement of 
the anterior iliac separation - the linear correlate of the iliac 
angle - which is simpler to measure and more reproducible. 
Mark A. Gittleman, MD, Division of General Surgery, was an 
invited speaker at the Annual Mastology Conference held April 
18-22, in Rosario, Argentina. Dr. Gittleman's topics included 
"Current Status of Sentinel Node Biopsies in Breast Cancer 
Diagnosis,• and "The United States Experience with Tamoxifen 
Trials." Dr. Gittleman was also an invited speaker at the 
American College of Surgeons Spring Meeting in Toronto, 
Canada, on April 23. He spoke at the Breast Ultrasound Post-
Graduate Course discussing "lnterventional Breast 
Ultrasound." In addition, he was a guest speaker at the Annual 
Meeting for the American Society of Breast Surgeons held May 
2-6 in La Jolla, Calif. Dr. Gittleman presented lectures on 
Stereotactic Breast Biopsy and Breast Ultrasound Certification 
programs. 
Barry H. Glassman, DMD, Division of General Dentistry, 
presented "The Use of EMG and Electrognathology in 
Craniomandibular Therapy" at the BioResearch TMD Annual 
Workshop Conference held in early May in Milwaukee, Wis. 
(Continued on Page 11) 
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Geoffrey G. Hallock, MD, Division of Plastic Surgery, recently 
had an article published in the Journal of Plastic and 
Reconstructive Surgery titled "A Prospective Study of the 
Accuracy of the Surgeon's Diagnosis and Significance of 
Positive Margins in Non-Melanoma Skin Cancers." This was 
an office-based experience with the removal of more than 
2,000 tumors showing that at least for non-horrifying skin 
cancers, which are very common, that only routine clinical 
follow-up rather than surgery or any other adjunct modality was 
usually sufficient long term to monitor those lesions, even if 
residual tumor had been noted on the pathologic exam. 
lndru T. Khubchandani, MD, Division of Colon and Rectal 
Surgery, was invited to operate and to speak at the 81h Biennial 
Congress of European Council of Coloproctology in Prague, 
Czech Republic, from April 29 to May 2. Dr. Khubchandani 
performed two hemorrhoidectomies and a procedure for 
fissure in ano in the operating room of Motel Hospital, which 
were telecast live to the auditorium of the Congress. Dr. 
Khubchandani was later interviewed by the media to give his 
impression regarding the facilities for surgery available in the 
Czech Republic. The story appeared on the front page of the 
local newspaper in addition to being publicized on national 
television. Later that week, Dr. Khubchandani chaired a panel 
on Anal Diseases and participated in symposia for 
hemorrhoids and laparoscopic surgery. 
On April16, Vincent R •. Lucente, MD, Acting Chairperson, 
Department of Obstetrics and Gynecology, was a guest 
speaker at the Bronx Gynecological and Obstetrical Society on 
the topic tiHed "Minimally Invasive Approaches to Stress 
Urinary Incontinence." Dr. Lucente was also invited to 
participate as visiting faculty for a symposium on 
"Comprehensive Gynecologic Laparoscopy" hosted by the 
University of Texas Southwestern Medical Center, April 27-28. 
In addition to presenting lectures, Dr. Lucente performed live 
telesurgery in Dallas. He was also the course director of the 
laparoscopy skills development lab. In addition, Dr. Lucente 
served as faculty director for a post-graduate course titled 
"Surviving the Business of Medicine" at the American College 
of Obstetrics and Gynecology's 50th Anniversary Clinical 
Meeting held April 28 to May 2 in Chicago, Ill. He also 
presented a clinical seminar titled "Vaginal vs. Abdominal vs. 
Laparoscopic Correction of Pelvic Support Defects." 
Thomas D. Meade, MD, Division of Orthopedic Surgery, 
Section of Ortho Trauma, was awarded the best paper 
presentation at the Pennsylvania Orthopaedic Society meeting 
held recently in Miami, Fla. Dr. Meade's presentation was 
titled "A New Approach ·to an Old Problem: Clavicle Fracture -
When to Operate?" 
Volume 13, Number 6 11 
Michael D. Pasquale, MD, Chief, Division of General Surgery 
and Trauma-Surgical Critical Care, and Thomas E. Wasser, 
PhD, Director of Clinical Epidemiology, coauthored the paper, 
"Outcome Analysis of Pennsylvania Trauma Centers: Factors 
Predictive of Nonsurvival in Seriously Injured Patients," which 
appeared in the March issue of The Journal of Trauma. 
Carmine J. Pellosie, DO, MPH, Chief, Section of 
Occupational Medicine, was a key speaker at a breakfast 
seminar on April18, where he presented issues concerning 
ergonomics after the repeal of the OSHA regulations. 
Representatives from Good Shepherd Outpatient 
Rehabilitation Clinic and Air Products and Chemicals, Inc., also 
presented. Individuals from regional, national, and 
international companies attended to learn about OSHA 
ergonomic information, ergonomic programs, and workplace 
job analysis. 
Robert D. Riether, MD, Program Director, Colon and Rectal 
Surgery Residency Program, and Herbert C. Hoover, Jr, MD, 
Chairperson, Department of Surgery, co-authored the review, 
"Hepatic Arterial Infusion Chemotherapy," which appeared in 
the March/April 2001 issue of Current Surgery. 
Lester Rosen, MD, Division of Colon and Rectal Surgery, was 
an invited speaker for the spring meeting of the Northeast 
Society of Colon and Rectal Surgeons held April27-29, in 
Providence, Rl. Dr. Rosen discussed the applications of 
"Virtual Colonoscopy as it Relates to Colonoscopy Cancer 
Screening." Additionally, Dr. Rosen was a co-author of the 
article, "Computerized Assessment of Complications Following 
Colorectal Surgery," which appeared in the April issue of 
Diseases of the Colon and Rectum. Computer software was 
analyzed to determine whether its predictions of co-morbidity 
and complications were comparable to what was interpreted in 
the medical record. The conclusion was that these predictions 
were quite accurate. As the uniformed discharge coding of 
commingled co-morbidity and complications is increasingly 
used to rapidly compute surgical outcomes, colon and rectal 
surgeons were urged to ensure compatibility of the actual and 




Upcoming Seminars, Conferences and 
Meetings 
Medical Grand Rounds 
Medical Grand Rounds are held on Tuesdays beginning at 
noon in the Auditorium of Lehigh Valley Hospital, Cedar Crest 
& 1-78, and via videoconference in the First Floor Conference 
Room at Lehigh Valley Hospital-Muhlenberg. 
Topics to be discussed in June will include: 
~ June 5 - Current Residency Research Projects 
~ June 12 - "Update in Therapies for Rheumatoid Arthritis" 
Have a great summer! Medical Grand Rounds will resume on 
September 4. 
For more information, contact Diane Biernacki in the 
Department of Medicine at (610) 402-5200. 
Pediatric Grand Rounds 
"Controversies Surrounding UTI's" will be presented on 
Tuesday, June 26, beginning at 8 a.m., in the hospital's 
Auditorium at Cedar Crest & 1-78. 
For more information, please contact Kelli Ripperger in the 
Department of Pediatrics at (610) 402-2540. 
Who's New 
The Who's New section of Medical Staff Progress Notes 
contains an update of new appointments, address changes, 
resignations, etc. Please remember to update your directory 
and rolodexes with this information. In addition, the Medical 
Staff Directory is now available on the e-mail Bulletin Board --
Directories. Updates will be made to the Medical Staff 
Directory in e-mail at the beginning of each month. 
Medical Staff 
Appointments 
Andrew K. Feng, MD 
(Solo Practice) 
1 Duke Lane 
Ambler, PA 19002-1522 
(215) 793-9686 
Department of Pediatrics 
Division of Hospital Based Pediatrics 
Section of Critical Care .Medicine 
Site of Privileges - LVH & LVH-M 
Provisional Limited Duty 
Number& 
Maryann P. Hartzell, DPM 
Allentown Family Foot Care 
1633 N. 26th Street 
Allentown, PA 18104-1801 
(610) 434-7000 
Fax: (610) 434-7029 
Department of Surgery 
Division of Orthopedic Surgery 
Section of Foot and Ankle Surgery 
Site of Privileges - L VH-M 
Provisional Active 
John J. Scaffidi, Jr., MD 
Total Women's Health Care 
2200 W. Hamilton Street, Suite 103 
Allentown, PA 18104-6329 
(610) 821-8321 
Fax: (610) 435-4599 
Department of Obstetrics and Gynecology 
Division of Primary Obstetrics and Gynecology 
Site of Privileges - LVH & LVH-M 
Provisional Active 
Jay D. Varrato, DO 
Lehigh Neurology 
1210 S. Cedar Crest Blvd., Suite 1800 
Allentown, PA 18103-6208 
(610) 402-8420 
Fax: (610) 402-1689 
Department of Medicine 
Division of Neurology 
Site of Privileges - LVH & LVH-M 
Provisional Active 
Practice Changes 
Lori A. Barnett, DPM 
(Now in practice with Coordinated Health Systems) 
1401 N. Cedar Crest Blvd. 
Suite 103 
Allentown, PA 18104-2307 
(610) 433-8080 
Fax: (610) 433-4376 
Meera Pathare, MD 
(No longer with Whitehall Medical Center) 
Drs. Bub and Young Family Medical Center 
619 Dalton Street 
P.O. Box 899 
Emmaus, PA 18049-0899 
(610) 967-3646 
Fax: (610) 965-6595 
(Continued on Page 13) 
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Robert D. Riether, MD 
(No longer with KSSRR, PC) 
Now in solo practice 
1230 S. Cedar Crest Blvd. 
Suite 303 
Allentown, PA 18103-6212 
(610) 402-1700 
Fax: (610} 435-5003 
Status Change 
Bruce A. Frankenfield, MD 
Department of Medicine 
Division of General Internal Medicine 
From: Affiliate 
To: Honorary 
One-Year Leave of Absence 
Dennis W. Kean, MD . 
Department of Pediatrics 
Division of General Pediatrics 
From: Active 
To: Active/LOA 
Michael A. Renaldo, DDS 
Department of Surgery 
Division of Oral and Maxillofacial Surgery 
From: Active 
To: Active/LOA 
Allied Health Professionals 
Appointments 
Michael D. Figard, PA-C 
Physician Extender 
Physician Assistant- PA-C 
(Orthopaedic Associates of Allentown- James C. Weis, MD) 
Site of Privileges - LVH & LVH-M 
Lori E. Holliday 
Physician Extender 
Technical 
(The Heart Care Group, PC - Joseph L. Neri, DO) 
Site of Privileges - LVH & LVH-M 
Number& 
Nancy L. Minnich, PA-C 
Physician Extender 
Physician Assistant- PA-C 
(Coordinated Health Systems - Leigh S. Brezenoff, MD) 
Site of Privileges - L VH-M 
Pamela K. Monceaux, CRNP 
Physician Extender 
Professional - CRNP 
(LVPG-Neonatology -lan M. Gertner, MD} 
Site of Privileges - LVH & LVH-M 
Daniel M. Schwartz, PhD, DABNM 
Associate Scientific 
Clinical Neurophysiologist 
(Surgical Monitoring Associates) 
(Supervising Physician - Mar1< C. Lester, MD) 
Site of Privileges - LVH & LVH-M 
Sandra K. Stufflet, RN 
Physician Extender 
Professional - RN 
(The Heart Care Group, PC - Steven Zelenkofske, DO) 
Site of Privileges - LVH & LVH-M 
Jennifer B. Wall, PA-C 
Physician Extender 
Physician Assistant- PA-C 
(Muhlenberg Primary Care, PC - Iqbal Sorathia, MD) 
Site of Privileges - LVH & LVH-M 
Change of Group and Supervising Physician 
Catherine E. Donati, CRNP 
Physician Extender 
Professional - CRNP 
From: Hamburg Family Practice Center 
13 
To: Allentown Anesthesia Associates Inc- Lisa A. Keglovitz, 
MD 
Site of Privileges - LVH & LVH-M 
Resignations 
Laurie A. West, PA-C 
Physician Extender 




THERAPEUTICS AT A GLANCE 
The following actions were taken at the Apri12001 Therapeutics Committee Meeting- Joseph Ottinger, R.Ph., MS, MBA, Christopher 
Moore, Pharm. D., Janine Barnaby, R.Ph., Jenny Boucher, Pharm.D. 
Drug Formulary Issues-
Bivalrudin, estrogen patches 
BWALIRUDIN/ANGIOMAX ™ 
INDICATIONS: Bivalirudin is indicated for use 
as an anticoagulant in patients with unstable 
angina undergoing percutaneous transluminal 
coronary angioplasty (PTCA). It is intended for 
use with aspirin and has only been studied in 
patients receiving concomitant aspirin. 
The safety and effectiveness ofbivalirudin has not 
yet been established in conjunction with platelet 
inhibitors other than aspirin, such as glycoprotein 
lib/lila inhibitors, or in patients with unstable 
angina who are not undergoing PTCA, or in 
patients with other acute coronary syndromes, 
although studies have recently been completed or 
are underway evaluating bivalirudin in these 
settings. 
CLINICAL PHARMACOLOGY: Bivalirudin 
(hirulog) is a 20 amino acid synthetic peptide 
reversible direct thrombin inhibitor modeled after 
the protein hirudin. It is a bivalent inhibitor of 
thrombin, binding to both the anion-binding 
exosite and enzyme catalytic site on both soluble 
and clot-bound thrombin. Unlike heparin, 
bivalirudin does not require a cofactor ( eg, 
antithrombin III) to produce its antithrombin 
activity. 
Bivalirudin transiently inhibits the active site of 
thrombin. Like lepirudin, it binds both the active 
site and exosite 1 on thrombin. Once bivalirudin 
is bound, thrombin slowly cleaves the bond on the 
amino-terminal domain of bivalirudin, which 
eliminates the active site inhibition. It remains 
bound to the exosite 1; however,· this is a low 
affinity interaction. Overall, unlike lepirudin, 
bivalirudin produces only transient inhibition of 
thrombin. 
Intravenous administration of bivalirudin 
produces a rapid, dose-dependent prolongation of 
activated clotting time (ACT), activated partial 
thromboplastin time (APTT), prothrombin time 
(Pn, and thrombin time (TT) 
PHARMACOKINETICS: Bivalirudin exhibits 
linear pharmacokinetics following intravenous 
administration. Bivalirudin blood levels have 
correlated with APTT, PT, and activated clotting. 
Bivalirudin is rapidly cleared, following 
intravenous administration, with a half-life of25 
minutes in patients with normal renal function. It 
is cleared from the plasma by a combination of 
renal mechanisms and proteolytic cleavage· 
Urinary excretion accounted for approximately 
20% of the total dose administered, regardless of 
route. 
Bivalirudin elimination correlates with glomerular 
filtration rate. Total body clearance is similar in 
subjects with normal renal function and those with 
mild renal impairment (60 to 89 mL/min). 
Clearance was reduced approximately 20% in 
patients with moderate and severe renal 
impairment and was reduced approximately 80% 
in patients on dialysis. The ACT should be 
monitored in patients with renal impairment. 
Bivalirudin is hemodialyzable. Approximately 
25% is cleared by hemodialysis. Dosage 
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adjustments are recommended for patients with 
moderate-to-severe renal impairment. See 
Table 1. 
Table 1: Pharmacokinetics and Dosage 
Adjustments ofBivalirudin in Renal Impairment: 
Renal Function Clearance Half-life o/o 




Nonnal (>90 mUmin) 3.4 25 0 
Mild (60-90 mUmin) 3.4 22 0 
Moderate (30-59 mUmin) 2.7 34 20 
Severe (10-29 mUmin) 2.8 57 60 
Dialysis-dependent 1 210 90 
patients (off dialysis) 
COMPARATIVE EFFICACY: 
Angioplasty 
Bivalirudin and heparin were compared in a 
double-blind trial enrolling 4,098 patients 
undergoing angioplasty for unstable or 
postinfarction angina (the Hirulog Angioplasty 
Study). Bivalirudin or heparin was administered 
immediately before angioplasty. Bivalirudin was 
dosed as a 1 mg/kg bolus followed by a 4-hour 
infusion of 2.5 mglkg/h and a 14- to 20-hour 
infusion at a rate of 
0.2 mglkg/h. Heparin was dosed as a bolus dose 
of 175 units/kg followed by an 18- to 24-hour 
infusion at a rate of 15 units/kg/h. The heparin 
dose was adjusted based on the ACT drawn at 5 
minutes and 45 minutes. If the ACT was less than 
350 seconds, the bivalirudin group was given a 
bolus of saline and the heparin group was given a 
bolus of 60 units/kg of heparin. Aspirin (300 to 
325 mg) was given to all patients. The primary 
study end point was death, myocardial infarction 
(MI), abrupt vessel closure, or rapid clinical 
deterioration of cardiac origin during 
hospitalization. The incidence of the primary end 
point in the intend-to-treat cohort did not differ 
between the treatment groups (11.8% with 
bivalirudin vs 12.9% with heparin; p=0.26). 
Bivalirudin therapy had a lower incidence of 
bleeding compared to heparin. Bivalirudin was 
associated with a lower incidence of 
retroperitoneal hemorrhage (0.2% vs 0.7%, 
p=0.02), need for transfusion (3.7% vs 8.6%, 
p<O.OOl), and major hemorrhage (3.8% vs 9.8%, 
p<0.001). The cumulative rate of death, MI, and 
repeated revascularization in the 6 months after 
angioplasty did not differ; 25.7% with bivalirudin 
and 26.6% with heparin in the intend-to-treat 
cohort (p=0.54), and 20.5% with bivalirudin and 
25.1% with heparin in the patients with 
postinfarction angina (p=0.17). In the subgroup 
of 704 patients with postinfarction angina, 
bivalirudin therapy was associated with a lower 
incidence of the primary end point (9 .1% vs 
14.2%, p=0.04) and a lower incidence of major 
bleeding (3% vs 11.1%, p<0.001) and minor 
bleeding (52.3% vs 68%, p<0.001). As in the 
larger study population, rates of death, Ml, and 
repeated revascularization in the 6 months 
following study drug administration did not differ. 
In another subgroup of 567 patients with 
thrombus-containing lesions, the incidence of the 
primary outcome and 6-month outcomes did not 
differ between treatment groups. A reanalysis of 
the results of this trial on an intent-to-treat basis 
identified 4312 patients, 2161 of whom were 
treated with bivalirudin are included in the 
product labeling. The reanalysis used a more 
sensitive definition ofMI than the original report. 
The primary endpoint of procedural failure (death, 
MI, clinical deterioration of cardiac origin 
requiring revascularization or placement of an 
aortic balloon pump, or angiographic evidence of 
abrupt vessel closure) occurred in 7.9% of 
bivalirudin-treated patients compared to 9.3% of 
heparin-treated patients. 
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Another trial was recently completed comparing 
a regimen of abciximab plus aspirin and heparin 
with a regimen of aspirin plus intraprocedural 
bivalirudin and abciximab if needed in 5,000 
patients undergoing routine PTCA with or without 
stenting (Comparison of Abciximab 
Complications with Hirulog [and Back-Up 
Abciximab] Events Trial [CACHET]). Results of 
this study have not yet been published. Another 
ongoing two-part study is enrolling 1,000 patients 
referred for percutaneous coronary interventions 
to assess bivalirudin versus heparin, with or 
without concomitant glycoprotein lib/lila 
inhibitor use, and another 6,000 patients referred 
for percutaneous coronary intervention who will 
be treated with bivalirudin monotherapy (with 
provisional glycoprotein lib/lila inhibitor use), 
heparin plus a glycoprotein lib/lila inhibitor, or 
bivalirudin plus a glycoprotein lib/lila inhibitor 
(The REPLACE Study). Another ongoing study 
is currently evaluating bivalirudin in patients 
undergoing percutaneous coronary interventions 
who are unable to tolerate heparin due to heparin-
induced thrombocytopenia or heparin-induced 
thrombocytopenia and thrombosis syndrome (the 
ATBAT 1st Inning Clinical Trial). 
CONTRAINDICATIONS, WARNINGS, 
AND PRECAUTIONS: Bivalirudin is 
contraindicated in patients with active major 
bleeding or hypersensitivity to bivalirudin or its 
components. 
Bivalirudin should not be administered via 
intramuscular injection. 
Bleeding is the primary adverse effect 
associated with bivalirudin. Bleeding can occur 
at any site, although when used in the PTCA 
setting, bleeding primarily occurs at the site of 
arterial puncture. An unexplained fall in blood 
pressure or hematocrit, or any unexplained 
symptom, should lead to consideration of a 
hemorrhagic event and discontinuation of 
bivalirudin therapy. 
Bivalirudin is in Pregnancy Category B. No 
evidence of impaired fertility or harm to the 
fetus was apparent in animal studies. 
Bivalirudin should be used in pregnancy only if 
clearly needed and the impact of the concurrent 
aspirin therapy on the fetus and pregnancy needs 
to be considered. It is not known if bivalirudin 
is excreted in human milk; therefore, caution is 
advised when bivalirudin is administered to a 
nursing woman. 
ADVERSE REACTIONS: Adverse reactions 
have included injection site pain, bleeding, 
hematoma formation, back pain, nausea, 
headache, and hypotension. The most common 
adverse effects reported in the Hirulog 
Angioplasty Study and the product labeling are 
summarized in Table 2. A complete list of the 
adverse reactions reported with bivalirudin can 
be found in the product labeling. 
Table 2: Adverse Effects Occurring in >5% of 
Patients in Either Bivalirudin or Heparin 
Treatment Group: 
Event Bivalirudin Heparin 
(n=2161) (n=2161) 
Major Bleeding 3.7% 9.3% 
with >3 g/dL fall in Hgb 1.9% 5.8% 
requiring transfusion 2% 5.7% 
Cardiovascular 
Hypotension 12% 17% 
Hypertension 6% 5% 
Bradycardia 5% 8% 
Gastrointestinal 
Nausea 15% 16% 
Vomiting 6% 8% 
Dyspepsia 5% 5% 
Genitourinary 
Urinary retention 4% 5% 
Miscellaneous 
Back pain 42% 44% 
Pain 15% 17% 
Headache 12% 10% 
Injection site pain 8% 13% 
Insomnia 7% 6% 
Pelvic pain 6% 8% 
Anxiety 6% 7% 
Abdominal pain 5% 5% 
Fever 5% 5% 
Nervousness 5% 4% 
Page 16 
DRUG INTERACTIONS: Limited drug 
interaction data are available at this time. 
Pharmacodynamic interactions have not been 
apparent in drug interaction studies with 
ticlopidine, abciximab, or low molecular weight 
heparin. Aspirin does not modify the activity of 
bivalirudin. 
An increased risk of bleeding exists in patients 
receiving heparin, warfarin, glycoprotein lib/lila 
inhibitors or thrombolytics in conjunction with 
bivalirudin therapy. 
RECOMMENDED MONITORING: In 
patients with renal impairment, ACT monitoring 
is recommended. 
DOSING: The recommended dosage of 
bivalirudin for patients with unstable angina and 
NOT CONCURRENTLY RECEIVING A 
GLYCOPROTEIN liB/IliA INHIBITOR 
scheduled to undergo PTCA is 1 mg/kg as an 
intravenous bolus dose followed by a 4-hour 
infusion at a rate of 2.5 mg/kg/h. After the 
completion of the initial 4-hour infusion, an 
additional infusion may be initiated at a rate of 
0.2 mg/kg/h for up to 20 hours. Treatment should 
be initiated just prior to PTCA. In patients with 
renal impairment, the dose should be reduced and 
ACT monitored. All patients should receive a 300 
to 325 mg dose of aspirin daily. No information 
is available on the effectiveness of bivalirudin 
without concurrent aspirin therapy. 
To prepare bivalirudin for administration, 5 mL of 
Sterile Water for Injection should be added to 
each 5 mL vial and the contents of the vial gently 
swirled until all material is dissolved. Each vial 
should be further diluted in 50 mL of 5% 
Dextrose in Water or 0.9% Sodium Chloride for 
Injection to yield a final concentration of 5 
mg/mL (eg, 1 vial in 50 mL, 2 vials in 100 mL, 5 
vials in 250 mL). The dose to be administered is 
adjusted according to the patient's weight. A table 
in the product labeling lists the weight-based dose 
in milliliters for the bolus dose and by infusion 
rate for the 4-hour and low-dose infusions. 
For the low-rate infusion, a lower concentration 
bag should be prepared by reconstituting the 
250 mg vials with 5 mL of Sterile Water for 
Injection and then further diluting the contents in 
500 mL of 5% Dextrose in Water or 0.9% Sodium 
Chloride for Injection to yield a final 
concentration of0.5 mg/mL 
Bivalirudin should be administered via an 
intravenous line. No other medications should be 
mixed with bivalirudin before or during 
administration. 
CONCLUSION: In the angioplasty setting, 
bivalirudin has been demonstrated to be at least 
as effective as heparin (and possibly more 
effective particularly in patients with recent MI) 
and to be associated with a lower incidence of 
major bleeding. However, the heparin arm of this 
study utilized a very aggressive dosing algorithm 
with a target ACT> 350 seconds .. The primary 
study end point was death, myocardial infarction 
(MI), abrupt vessel closure, or rapid clinical 
deterioration of cardiac origin during 
hospitalization. The incidence of the primary end 
point in the intend-to-treat cohort did not differ 
between the treatment groups (11.8% with 
bivalirudin vs 12.9% with heparin; p=0.26). The 
cumulative rate of death, MI, and repeated 
revascularization in the 6 months after angioplasty 
did not differ; 25.7% with bivalirudin and 26.6% 
with heparin in the intend-to-treat cohort (p=0.54), 
and 20.5% with bivalirudin and 25.1% with 
heparin in the patients with postinfarction angina 
(p=0.17). Therefore, routine use of this agent in 
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and 20.5% with bivalirudin and 25.1% with 
heparin in the patients with postinfarction angina 
(p=0.17). Therefore, routine use of this agent in 
lieu of unfractionated heparin cannot be 
recommended . 
However, for patients unable to tolerate heparin 
or at a high risk for major bleeding, bivalirudin 
use may be the preferred agent, as neither 
lepirudin or argatroban have FDA approved 
indications, and bivalrudin may be less costly than 
either of the other two direct thrombin inhibitors. 
More data are necessary on the use ofbivalirudin 
in additional settings and in combination with 
other agents, particularly glycoprotein lib/lila 
inhibitors, clopidogrel, and thrombolytics before 
widespread use can be advocated. The CACHET 
and REPLACE trials will provide some guidance 
in this area. A patient treatment would cost (at a 
minimum) $350. Dosing is predicated on a 
patient's weight and duration of therapy can also 
vary significantly, thereby, effecting treatemnt 
costs. 
The Therapeutics Committee recommend 
approval for this agent for use in patients with 
documented previous heparin induced 
thrombocytopenia. Use with glycoprotein lib/lila 
agents will require dosing adjustments. 
Esclim patches were selected as the 
preferred estrogen-based patch. The Pharmacy 
will use this patch system to provide a basis for an 
automatic therapeutic substitution for all other 
currently available estrogen-based patch systems. 
These products were considered interchangeable 
as far as efficacy and safety were concerned. 
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c fT dennal Estro2en Thcraoies rans oma!!]§QnO 
Brand name Estradenn Climara Vivelle A lora Vivelle- Esc lim 
DOT 
Dosage Twice Once Twice Twice Twice Twice 
regimen weekly weekly weekly weekly weekly weekly 
Available 0.05 0.025 0.375 0.05 0.375 0.025 
strengths 0.1 0.05 0.05 O.o75 0.05 0.0375 
(mgld) O.o75 0,075 0.1 O.o75 0.05 
0.1 0.1 0.1 0.075 
0.1 
Placement Abdomen, Abdomen, Abdomen, Abdomen, Abdomen, Buttocks, 
buttocks buttocks buttocks hip, buttocks thigh, 
buttocks arm 
Acutal $20.24 $21.38 $21.65 $18.23 $22.18 $19.60 
weighted 
cost/month • 
$0.01 Hospital $2.45- $2.54- $2.62- $2.21- $2.68-
Acqusition $2.67 $2.76 $2.78 $2.38 $2.84 
cost-each 
*Source: First Databank, Inc,: First DataBank Pricing Database, 4/2000 
Fenojibrate rejected 
At the last therapeutics committee meeting, data 
were presented that demonstrate no clinical 
advantage of fenofibrate ( tricor) over the currently 
available fibric acid derivative at L VH 
(gemfibrozil). Although never compared head to 
head, these two agents have comparable effects on 
serum lipids. The adverse effect profile of both 
agents is nearly identical. In light of this data the 
recommendation of the committee is to not add 
fenofibrate to formulary. There appears to be no 
clinical advantage over gemfibrozil other than 
once daily dosing. No data are available on the 
effects of fenofibrate on morbidity and mortality 
from coronary artery disease. Other fibrates have 
shown a slowing of the progression of coronary 
artheroscelrosis and a decrease in the incidence of 
coronary events, but no effect on total mortality. 
There may be more data in the near future. The 
committee voted to allow the substitution of 
gemfibrozil600 mg bid for fenofibrate in doses of 
67-200 mg/day. 
Medication Error Prevention Tips 
See attached sheet for some examples. 
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·- o not use these dan 'lf!erous reviations or abb ose esl[!natwns d d . 
Abbreviation/ Intended ~eanrnng ~isinterpretation Correction 
Dose Expression 
Apotheca1y symbols dram Misunderstood or misread (symbol for Use the metric 
minim dram misread for "3,. and minim system. 
misread as "mL"). 
AU aurio uterque (each ear) Mistaken for OU ( oculo uterque-each Don't use this 
eye). abbreviation. 
DIC discharge Premature discontinuation of Use "discharge" and 
discontinue medications when D/C (intended to "discontinue . ., 
mt::au ··uis~,.;llargt::" ") lias lJt::t::Il 
misinterpreted as "discontinued" when 
followed by a list of drugs. 
Drug names Use the complete 
ARA-A vidarabine cytarabine (ARA-C) spelling for drug 
.AZT zidovudine (RETROYm) azathioprine names. 
CPZ COMPAZINE chlorpromazine 
(prochlorperazine) 
DPT DEMEROL-PHENERGAN- diphtheria-pertussis-tetanus (vaccine) 
THORAZINE 
HCl hydrochloric acid potassium chloride (The "H" is 
misinterpreted as "K. ") 
HCT hydrocortisone hydrochlorothiazide 
HCTZ hydrochlorothiazide hydrocortisone (seen as HCT250 mg) 
MgS04 magnesium sulfate morphine sulfate 
MS04 morphine sulfate magnesium sulfate 
MTX methotrexate mitoxantrone 
I 
TAC triamcinolone tetracaine, ADRENALIN, cocaine 
ZnS04 zinc sulfate morphine sulfate 
Stemmed names 
"Nitro" drip nitroglycerin infusion sodium nitroprusside infusion 
IJ.g microgram Mistaken for "mg" when handwritten. Use "meg." 
o.d. or OD once daily Misinterpreted as "right eye" (OD- Use "daily." 
oculus dexter) and administration of 
oral medications in the eve. 
TIW ortiw three times a week Mistaken as "three times a day." Don't use this 
abbreviation. 
per os orally The "os" can be mistaken for "left Use "PO," "by 
eve." mouth," or "orally." 
q.d. or QD every day Mistaken as q.i.d., especially ifthe Use "daily" or "every 
period after the "q" or the tail ofthe day." 
"q" is misunderstood as an "i." 
lqn nightly or at bedtime Misinterpreted as "qh" (everv hour). Use "nightly." 
qhs nightly at bedtime Misread as every hour. Use "nightly." 
!q6PM, etc. every evening at 6 PM Misread as every six hours. Usc 6 PM "nightly." 
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do t no use th ese hh angerousa revzatzons or ose eszgnj zons tJ tJ . at' 
Abbreviation/ Intended Meaning Misinterpretation Correction 
Dose Expression 
q.o.d. or QOD every other day Misinterpreted as "q.d." (daily) or Use "every other 
"q.i.d. (four times daily) if the "o" is day." 
poorly written. 
sub q subcutaneous The "q" has been mistaken for "every" Use "subcut." or write 
(e.g., one heparin dose ordered "sub q "subcutaneous." 
2 hours before surgery" misunderstood 
as every 2 hours before surgery]. 
sc subcutaneous Mistaken for SL (sublingual). Use "subcut." or write 
"subcutaneous." 
U oru unit Read as a zero (0) or a four (4), "Unit" has no 
causing a 1 0-told overdose or greater acceptable 
( 4U seen as "40" or 4u seen as 44"). abbreviation. Use 
"unit." 
IU international unit Misread as IV (intravenous). Use "units." 
cc cubic c~nlim~l~rs Misr~ad as "U" (unils). Us~ "mL." 
x3d for three days Mistaken for "three doses." Use "for three days." 
BT bedtime Mistaken as "BID" (twice daily). Use "hs." 
ss sliding scale (insulin) Mistaken for "55.'' Spell out .. sliding 
or 1h (apothecary) scale." Use "one-half' 
or use " 1h." 
>and< greater than and less than Mistakenly used opposite of intended. Use "greater than" or 
"less thn.n." 
I (slash mark) separates two doses or Misunderstood as the number 1 ("'25 Do not use a slash 
indicates "per" unit/10 units" read as "110" units. mark to separate 
doses. 
Use "per." 
Name letters and Inderal 40 mg Misread as Inderal 140 mg. Always use space 
dose numbers run between drug name, 
together dose and unit of 
!(e.g., Inderal40 mg). measure. 
Zero after decimal 1 mg Misread as 10 mg ifthe decimal point Do not use terminal 
point (1.0) is not seen. zeros for doses 
expressed in whole 
numbers. 
No zero before 0.5 mg Misread as 5 mg. Always use zero 
decimal dose before a decimal when 
(.5 mg) the dose is less than a 
whole unit. 
A Targeted, Multidisciplinary Approach to Improving Patient Care 
In the fall of 1999, the Institute of Medicine published To Err Is Human, which focused on 
building a safer health system through process and human factors analysis, improving error 
reporting systems, setting performance standards, and creating "systems of safety" in health care 
organizations. 
In response to the 10M's report, LVHHN embarked upon a multidisciplinary, systems approach 
to improving care and reducing medical errors: the Primum Non Nocere projects for FYOl. 
These "First Do No Harm" projects are focused, practical approaches to improving care through: 
1) improved communication 
2) fail-safe process design 
3) evidence-based protocol use 
In March 2001, the Institute of Medicine released its second report on health care, "Crossing the 







To address systems issues and adhere to these 6 principles, we have created the Multidisciplinary 
Council. This quality assurance council reviews select QA cases and develops hospital-wide 
systems solutions. In addition, as we move forward with FY02 PNN projects, we continue to 
keep these principles in mind. 













Site identification team 
Primum Non Nocere 
SOME PROJECT HIGHLIGHTS 
Improve weight documentation and fluid overload 
management/Communicate wt change >3lbs to physician 
Use of preprinted order sets 
Improve heparin order sheet use/Decrease DVTs/PE/Use blue bands 
for patients on any anticoagulation 
Decrease complications 
Improve postop management 
Decrease risk of falls 
Decrease incidence 
Improve preprinted order use/Decrease waste 
Improve medication error reporting/Non-punitive reporting 
policy/Safer pain management with PCA/epidural pumps 
Decrease Foley catheter use/Institute urinary retention protocol/Use 
bladder scanners 
Decrease incidence. Institute Braden scale for monitoring 
Improve patient and employee safety with safer devices 
Institute protocols for proper surgical site identification 
Page21 
***A word on DVT and PE complications*** 
This project focuses on appropriate treatment of patients with these diagnoses, and on proper 
prophylaxis of patients to avoid DVT/PE in the hospital. Our institutional average incidence of 
DVT as a secondary diagnosis is less than one percent (FYOl data); however, some individual 
departments and divisions have rates that exceed this by 200%. Improvements can be best 
accomplished by using preprinted orders for anticoagulation in patients at risk for DVT/PE. As 
Dr. Mark Cipolle comments, "Chart reviews indicate that as many as 50% of patients who 
develop DVT as a complication did not have appropriate prophylaxis in our institution. There is 
a large amount of treatment variation for DVT/PE; we will be striving to reduce this variation, 
and will encourage the use of LMWH." 
Your cooperation with preprinted order use, reporting of preventable adverse events through the 
Event Report process, legible orders and printed names or stamps (available through Medical 
Staff services), and pro-active identification of patient and employee safety issues, will ensure 
everyone's success in improving patient care. Finally, CAPOE is coming! 






News from the Library 
OVID Training. 
The Library has completely converted to OVID's on-
line MEDLINE system. This Web-based system is 
updated daily by Ovid. Call Barbara Jobst in the 
Health Sciences Library at 610-402-8408 to schedule 
a one-on-one training session. 
New Library Publications. 
CC &I-78 
"Heart Disease: A Textbook of Cardiovascular 
Medicine," 6th edition. 
L VH-Muhlenberg 
"Krause's Food, Nutrition, and Diet Therapy," lOth 
edition. 
"Harrison's Principles of Internal Medicine," 15th edition. 
17th & Chew Streets 
"Principles and Practice of Emergency Medicine," 4th 
edition. 
"Psychiatric Clinics of North America"- Volume 24, 
No.1 
Topic: Generalized Anxiety Disorder. 
Computer-Based Training (CBT): 
Computer Based Training (CBT) programs are available for 
L VHHN staff. Topics covered by the CBT programs include: 
Access 2.0 Power-Point 4.0 
Windows NT 4 Word 97 
Excel 97 Access 97 
PowerPoint 97 Lotus 1-2-3 Millennium 
WordPerfect 8 E-mail GUI 
PHAMIS LastWord Inquiry Only commands 
1 
CBT programs replace the instructor-led classes previously 
held at Lehigh Valley Hospital. A proctor will be in the room 
with the learner while he/she takes the CBT, but the learner 
will control the pace and objectives of the learning. 
Computer Based Training takes place in Suite 401 of the John 
& Dorothy Morgan Cancer Center (the computer training 
room) and in the Muhlenberg Hospital Center computer 
training room (off the front lobby). The schedule of 
upcoming dates is as follows: 
CBT sessions for JDMCC, suite 401 are as follows: 
June 26, Noon- 4 pm 
August 7 8 am - Noon 
Sessions at MHC, I.S. Training room are as follows: 
July 17, Noon- 4 pm 
Twelve slots are available for each session. 
To register, please contact Suzanne Rice via e-mail or at 610-
402-2475 with the following: 
date of session 
second date choice 
department 
phone number 
You will receive an e-mail confirming your choice within two 
business days. If you have any questions, please contact Craig 
Koller at 610-402-2413 or through e-mail. 
Any questions, concerns or comments on articles from CEDS, please 
contact Bonnie Schoeneberger 610-402-2584 
Educational Activities 
Obstetrics & Gynecology, 
Joseph A. Miller, M.D. 
Resident Research Day 
Friday, June 1, 2001 
Lehigh Valley Hospital 
Cedar Crest & 1-78, Auditorium 
7:30am Registration/Continental Breakfast 
8:00 am Opening Remarks 
Vincent Lucente, MD, MBA, FACOG 
8:05 am Welcome Remarks 
Robert Laskowski, MD, MBA 
Scientific Session- Moderator: Orion Rust. MD. FACOG 
8:10 am Ancient Egyptian Medicine and Lessons for Today 
State of the Union for ACOG 
W. Benson Harer, Jr., MD, FACOG 
9:10am Concomitant Vaginal Surgery with Tension-Free 
Vaginal Tape Pubovaginal Sling for the Treatment 
of Female Stress Urinary Incontinence and Pelvic 
Support Defects 
T. Russell Horton, MD 
9:40 am Evaluation of a Resident-Run Community Service 
Project 
Rochelle Steiner, MD 
10:30 am Early Feeding After Gynecologic Surgery: An 
Evidence-Based Talk 
Fidel Valea, MD, FACOG 
11:30 am Clinical Outcomes of the Fetus with Preterm 
Premature Rupture of Membranes <30 weeks 
Eric Grossman, MD 
12:00 pm Treatment of the Macrosomic Fetus-
Araba Sam, MD 
12:30 pm Closing Remarks 




Attending physicians, residents, medical students, nurses and 
other healthcare professionals are invited to continue their 
career development and medical education by attending this 
educational offering. 
ObJectives: 
At the completion of this program, the participant will be able 
to: compare how the science of medicine has changed but 
human nature has not; and evaluate evidence-based 
recommendations regarding early feeding after gynecologic 
surgery. 
Accreditation: 
Lehigh Valley Hospital and Health Network is accredited by 
the Pennsylvania Medical Society to sponsor continuing 
medical education programs for physicians. 
Lehigh Valley Hospital and Health Network designates this 
continuing medical education activity for 4 credit hours in 
Category 1 of the Physician's Recognition Award of the 
American Medical Association and the Pennsylvania Medical 
Society membership requirement. 
All faculty participating in continuing medical education 
programs sponsored by Lehigh Valley Hospital and Health 
Network are expected to disclose to the program audience any 
real or apparent conflicts of interest related to the content of 
their presentations. 
Registration: 
There is no registration fee for this program. 
To register, e-mail Bonnie.Schoeneberger@lvh.com the 
following information: 
Name, Title (MD, DO, RN or other) 
Company and department 
Address 
Day time phone 
Social Security Number 
For questions or for more information: 
E-mail Bonnie.Schoeneberger@lvh.com or call Bonnie @ 
610-402-2584. 
* * * * * * * * * * * * * * * * * * * 
TRAUMA NURSE COURSE 
Module I - Principles of Care 
This is a self-learning package that needs to be completed 
prior to attending any modules of the course. Please register 
for this the same as all other modules. The "Principles of 
Care" book, exam and evaluation will be mailed to you. Please 
allow at least two weeks for completion. Exams and 
evaluations must be returned by May 28, 2001. 
Adult Trauma 
Day 1 6/4/01 0800-1630 EMI 
Topics Covered: 
Trauma System Overview 
Pain Management Principles 
Shock/ Anesthesia with METI Simulator 
PCA/Epidural 
Pregnant Trauma Patient 
Maxillofacial Trauma 
Head Injury 
SCI Injury and Assessment 
Ethical Dilemmas 





Complications of Trauma 
Burn Injury 
Organ Donation 
Pediatric Trauma 6/6/01 0800-1630 EMI 
Topics Covered: 
Intro to Pediatric Trauma 
Pediatric Head Injury 
Pediatric Chest/Thoracic 
Pediatric MS Injuries 
Pediatric Abdominal Injuries 
Pediatric IV Therapy/Fluid Management Workshop 
Part I - IV Therapy 
Part II - Fluid and Medication Calculation 
Skill Stations: 
Pediatric Resuscitation/Shock and Anesthesia 
Pain Management 
Spinal Cord Injury 
Child Abuse 
Family Crisis Intervention 
Burn Trauma 6/7/01 0800-1630 EMI 
To Register: See **Registration Information Below** 
* * * * * * * * * * * * * * * * * * * 
3 
ONCOLOGY EDUCATION SERIES: 
BREAST CANCER UPDATE 
JUNE 6,2001 7:30AM-4:15PM 
JDMCC CONFERENCE ROOM 1N1B 
Agenda: 
7:30am Registration 
7:45 am Overview of Breast Cancer 
Elisabeth Ladd, RN, MSN 
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8:45 am New Imaging Modalities in the Diagnosis of 
Breast Cancer- Dr. John Pearce 
9:45 am Advances in the Staging of Breast Cancer: Sentinel 
Node Biopsy -Dr. Gerry Sherwin 
10:30 am Break 
10:45 am Pathological Advances in the Diagnosis and 
Staging of Breast Cancer - Dr. Elizabeth Dellers 
11:30 am Breast Cancer Prevention/STAR 
Deborah Kane, RN, BS 
12:00 pm Lunch 
12:45 pm Cancer Genetics- Elisabeth Ladd, RN, MSN 
1:30pm Breast Reconstruction- Dr. Samina Wahhab 
2:15 pm Break 
2:30pm What Are Our Patients Telling Us? 
Nadesda Mack, RN, BSN 
3:15pm Survivors' Perspective 
4:00 pm Summary and Evaluation 
Accreditation: 
Lehigh Valley Hospital and Health Network is approved as a 
provider of Continuing Nursing Education (CNE) as approved 
by the Pennsylvania Nurses Association, an accredited 
approver of continuing education in nursing by the 
American Nurses Credentialing Center's Commission on 
Accreditation. This course has been approved for 8.7 PSNA 
Contact Hours for registered nurses attending the entire 
program and completing the evaluation tool. 
To Register: See **Registration Information Below** 
********************** *** 
LVHHN AND EASTERN PA CHAPTER AANN 
Present ••• 
NEURO EVENING SEMINAR 
Wednesday, June 6, 2001 
5:00pm- 8:30pm 
Lehigh Valley Hospital Auditorium, CC & 1-78 
Schedule: 
4:30pm Registration 
5:00pm Pain Management in MS 
Nancy Eckert & Stacy Statler 
6:00 pm Break 
6:15 pm Neuroscience and Socialized Medicine 
Dr. Mark Lester 
7:15pm Dysphagia After Cervical Surgery 
Claranne Mathiesen and Patty Schlegel 
8:15pm Evaluation 
Accreditation: 
Lehigh Valley Hospital and Health Network is approved as a 
provider of Continuing Nursing Education (CNE) as approved 
by the Pennsylvania Nurses Association, an accredited 
approver of continuing education in nursing by the 
American Nurses Credentialing Center's Commission on 
Accreditation. This course has been approved for 3.9 PSNA 
contact hours for registered nurses attending the entire 
program and completing the evaluation tool. 
4 
Page26 
**Register Information: ** 
THERE IS NO FEE TO ATTEND THESE PROGRAMS. 
LVHHNStatT 
Please access the Bulletin Board entitled Forms_Nursing. 
Select the Cont. Education Registration Form. 
Right click on the title and choose "Use Form". 
Complete all areas (refer to "How To Register" for more help 
on using forms). 
Use the comments section to provide us with any additional 
information that may be useful. 
We will be unable to process incomplete registrations. 
PennCARE Affiliates and Staff without E-Mail Access 
Please either call (610-402-2277) or fax (610-402-2203) the 
following information: name, hospital affiliation, position, 
mailing address, social security#, and daytime phone#. 
We will be unable to process incomplete registrations. 
If you have any questions, please call the Center for 
Educational Development and Support at 610-402-2277. 
Any questions, concerns or comments on articles from CEDS, please 
contact Bonnie Schoeneberger 610-402-2584 
Sunday Monday Tuesday Wednesday Thursday Friday Saturday 
June 2001 
1 2 
730am -12:40 pm 




3 4 5 6 7 8 9 
12noon Colon/Rectal 7am Family Practice GR- 730am- 4:15pm Breast 12noon Combined TB- 7am OBGYN GR-CC-CL 1 
TB-JDMCC-CR1 JDMCC - 1 A/1 B Cancer Update JDMCC - JDMCC-CR1 12noon Breast TB-JDMCC-
7am Surgical GR-CC-Aud 1A/1B CR1 
Bam Pediatric GR- CC-Aud 5:00pm - 8:30 pm Neuro 
12 noon Medical GR-CC- Evening Seminar CC -
Aud Aud 
10 11 12 13 14 15 16 
7am Surgical GR-CC-Aud 12noon Pulmo TB- 12noon Gl TB-JDMCC 7am OBGYN GR-CC-CL 1 
Bam Pediatric GR-CC-Aud JDMCC-CR1 CR-1 12noon Breast TB-JDMCC-
12 noon Medical GR-CC- CR1 
Aud 
17 18 19 20 21 22 23 
12noon Colon/Rectal Bam Pediatric GR-CC-Aud 12noon ENT TB- 7am OBGYN GR-CC-CL 1 
TB-JDMCC-CR1 JDMCC-CR1 12noon Breast TB-JDMCC-
CR1 
24 25 26 27 28 29 30 
Sam Pediatric GR-CC-Aud 12noon Combined TB - 7am OBGYN GR-CC-CL 1 
12noon Urology TB-JDMCC- CC- Aud 12noon Breast TB-JDMCC-
CR1 CR1 
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Permit No. 1922 
Medical Staff Progress Notes 
is published monthly to 
inform the Medical Staff of 
Lehigh Valley Hospital and 
employees of important 
issues concerning the 
Medical Staff. 
Articles should be submitted 
to Janet M. Seifert, Physician 
Relations, Lehigh Valley 
Hospital, Cedar Crest & 1·78, 
P.O. Box 689, Allentown, PA 
18105·1556, by the 15th of 
each month. If you have any 
questions about the 
newsletter, please call Mrs. 
Seifert at (61 0) 402-8590. 
